LIFE Annual EBIT
-$54.92 M
-$8.52 M-18.35%
31 December 2023
Summary:
As of February 3, 2025, LIFE annual earnings before interest & taxes is -$54.92 million, with the most recent change of -$8.52 million (-18.35%) on December 31, 2023. During the last 3 years, it has fallen by -$39.01 million (-245.16%).LIFE EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LIFE Quarterly EBIT
-$16.64 M
-$677.00 K-4.24%
31 March 2024
Summary:
As of February 3, 2025, LIFE quarterly earnings before interest & taxes is -$16.64 million, with the most recent change of -$677.00 thousand (-4.24%) on March 31, 2024. Over the past year, it has dropped by -$3.85 million (-30.10%).LIFE Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LIFE TTM EBIT
-$58.77 M
-$3.85 M-7.01%
31 March 2024
Summary:
As of February 3, 2025, LIFE TTM earnings before interest & taxes is -$58.77 million, with the most recent change of -$3.85 million (-7.01%) on March 31, 2024. Over the past year, it has dropped by -$11.96 million (-25.54%).LIFE TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LIFE EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -18.4% | -30.1% | -25.5% |
| 3 y3 years | -245.2% | -32.2% | -42.2% |
| 5 y5 years | -67.3% | -183.1% | -155.8% |
LIFE EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +275.0% | -994.9% | +891.0% |
ATyr Pharma EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | -$16.64 M(+4.2%) | -$58.77 M(+7.0%) |
| Dec 2023 | -$54.92 M(+18.3%) | -$15.96 M(+26.5%) | -$54.92 M(+17.1%) |
| Sept 2023 | - | -$12.62 M(-7.0%) | -$46.91 M(-1.8%) |
| June 2023 | - | -$13.56 M(+6.0%) | -$47.79 M(+2.1%) |
| Mar 2023 | - | -$12.79 M(+60.8%) | -$46.81 M(+0.9%) |
| Dec 2022 | -$46.40 M(+36.4%) | -$7.95 M(-41.1%) | -$46.40 M(-1.5%) |
| Sept 2022 | - | -$13.49 M(+7.2%) | -$47.09 M(+13.9%) |
| June 2022 | - | -$12.58 M(+1.7%) | -$41.33 M(+5.5%) |
| Mar 2022 | - | -$12.38 M(+43.3%) | -$39.19 M(+15.2%) |
| Dec 2021 | -$34.02 M(+113.8%) | -$8.64 M(+11.8%) | -$34.02 M(+12.2%) |
| Sept 2021 | - | -$7.73 M(-26.0%) | -$30.32 M(+4.2%) |
| June 2021 | - | -$10.45 M(+45.0%) | -$29.10 M(+16.5%) |
| Mar 2021 | - | -$7.20 M(+45.8%) | -$24.97 M(+56.9%) |
| Dec 2020 | -$15.91 M(-30.8%) | -$4.94 M(-24.1%) | -$15.91 M(-6.0%) |
| Sept 2020 | - | -$6.51 M(+3.1%) | -$16.93 M(+6.4%) |
| June 2020 | - | -$6.32 M(-439.9%) | -$15.92 M(+4.4%) |
| Mar 2020 | - | $1.86 M(-131.2%) | -$15.24 M(-33.7%) |
| Dec 2019 | -$22.98 M(-30.0%) | -$5.96 M(+8.4%) | -$22.98 M(-0.0%) |
| Sept 2019 | - | -$5.50 M(-2.5%) | -$22.98 M(-4.9%) |
| June 2019 | - | -$5.64 M(-4.0%) | -$24.16 M(-15.2%) |
| Mar 2019 | - | -$5.88 M(-1.4%) | -$28.48 M(-13.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$32.82 M(-30.4%) | -$5.96 M(-10.7%) | -$32.82 M(-13.8%) |
| Sept 2018 | - | -$6.68 M(-33.0%) | -$38.06 M(-9.8%) |
| June 2018 | - | -$9.96 M(-2.5%) | -$42.21 M(-4.4%) |
| Mar 2018 | - | -$10.22 M(-8.8%) | -$44.15 M(-6.3%) |
| Dec 2017 | -$47.15 M(-18.6%) | -$11.20 M(+3.4%) | -$47.15 M(-2.7%) |
| Sept 2017 | - | -$10.83 M(-9.1%) | -$48.47 M(-5.9%) |
| June 2017 | - | -$11.91 M(-9.9%) | -$51.51 M(-6.4%) |
| Mar 2017 | - | -$13.21 M(+5.5%) | -$55.04 M(-5.0%) |
| Dec 2016 | -$57.94 M(+21.7%) | -$12.53 M(-9.7%) | -$57.94 M(-6.4%) |
| Sept 2016 | - | -$13.87 M(-10.2%) | -$61.90 M(+4.3%) |
| June 2016 | - | -$15.43 M(-4.2%) | -$59.34 M(+8.3%) |
| Mar 2016 | - | -$16.11 M(-2.2%) | -$54.81 M(+15.1%) |
| Dec 2015 | -$47.62 M(+102.2%) | -$16.48 M(+45.7%) | -$47.62 M(+28.1%) |
| Sept 2015 | - | -$11.31 M(+3.8%) | -$37.16 M(+15.8%) |
| June 2015 | - | -$10.90 M(+22.1%) | -$32.08 M(+20.9%) |
| Mar 2015 | - | -$8.92 M(+48.0%) | -$26.55 M(+12.7%) |
| Dec 2014 | -$23.55 M(+20.5%) | -$6.03 M(-3.2%) | -$23.55 M(+34.4%) |
| Sept 2014 | - | -$6.23 M(+16.2%) | -$17.52 M(+55.2%) |
| June 2014 | - | -$5.36 M(-9.6%) | -$11.29 M(+90.4%) |
| Mar 2014 | - | -$5.93 M | -$5.93 M |
| Dec 2013 | -$19.54 M | - | - |
FAQ
- What is aTyr Pharma annual earnings before interest & taxes?
- What is the all time high annual EBIT for aTyr Pharma?
- What is aTyr Pharma annual EBIT year-on-year change?
- What is aTyr Pharma quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for aTyr Pharma?
- What is aTyr Pharma quarterly EBIT year-on-year change?
- What is aTyr Pharma TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for aTyr Pharma?
- What is aTyr Pharma TTM EBIT year-on-year change?
What is aTyr Pharma annual earnings before interest & taxes?
The current annual EBIT of LIFE is -$54.92 M
What is the all time high annual EBIT for aTyr Pharma?
aTyr Pharma all-time high annual earnings before interest & taxes is -$14.64 M
What is aTyr Pharma annual EBIT year-on-year change?
Over the past year, LIFE annual earnings before interest & taxes has changed by -$8.52 M (-18.35%)
What is aTyr Pharma quarterly earnings before interest & taxes?
The current quarterly EBIT of LIFE is -$16.64 M
What is the all time high quarterly EBIT for aTyr Pharma?
aTyr Pharma all-time high quarterly earnings before interest & taxes is $1.86 M
What is aTyr Pharma quarterly EBIT year-on-year change?
Over the past year, LIFE quarterly earnings before interest & taxes has changed by -$3.85 M (-30.10%)
What is aTyr Pharma TTM earnings before interest & taxes?
The current TTM EBIT of LIFE is -$58.77 M
What is the all time high TTM EBIT for aTyr Pharma?
aTyr Pharma all-time high TTM earnings before interest & taxes is -$5.93 M
What is aTyr Pharma TTM EBIT year-on-year change?
Over the past year, LIFE TTM earnings before interest & taxes has changed by -$11.96 M (-25.54%)